Veru Inc. (VERU)
VERU trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$2.19
-8.94% on the day
Market cap
$37.3M
Nano cap
Revenue · 2024
$16.9M
+3.6% on 2023
Net income · 2024
-$37.8M
-223.9% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2024.
Profile
| Field | Value |
|---|---|
| Ticker | VERU on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | Not reported by the screener |
| SEC CIK | 0000863894 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | WI |
Financials · 2024
| Line | Value |
|---|---|
| Revenue | $16.9M |
| Net income | -$37.8M |
| Operating income | -$36.2M |
| Net margin | -223.9% |
| Operating margin | -214.2% |
| Revenue growth | +3.6% |
| Cash | $26.6M |
| Total assets | $39.8M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 2.2× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-07-02 |
| Latest annual report FORM 10-K | 10-K | 2025-12-17 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-08-10 |
| Latest current report | 8-K | 2026-09-08 |
| Latest proxy | DEFA14A | 2026-01-28 |
Source: SEC EDGAR submissions feed, 1,000 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NSRX | Nasus Pharma Ltd. | $3.16 | -4.82% | $37.0M |
| LITS | Lite Strategy Inc. | $1.21 | -0.82% | $36.8M |
| IXHL | Incannex Healthcare Inc. | $2.91 | +0.34% | $36.5M |
| EDSA | Edesa Biotech Inc. Common Shares | $2.85 | -3.23% | $38.4M |
| FLNA | Filana Therapeutics Inc. | $0.7434 | -3.39% | $35.9M |
| SCYX | SCYNEXIS Inc. | $3.99 | -0.99% | $39.7M |
| CRVO | CervoMed Inc. | $2.27 | -9.56% | $34.3M |
| IBO | Impact BioMedical Inc. | $3.98 | -1.24% | $34.0M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier